相关实验视频

Updated: May 16, 2025

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

酸耐酸酸酶5 (TRAP5) 在过敏性喘期间促进乙氨基细胞迁移

Médea Padra¹, Jesper Bergwik², Anna Adler²

¹Lund University Department of Clinical Sciences Lund, Respiratory Medicine, Allergology and Palliative Medicine, Lund, Sweden; medea.padra@med.lu.se.

American journal of respiratory cell and molecular biology

|April 2, 2025

概括

耐酸酸酶5 (TRAP5) 通过影响免疫细胞招募和炎症,在过敏喘中发挥关键作用. 抑制TRAP5可能为管理过敏气道炎症提供新的治疗策略.

科学领域:

免疫学免疫学免疫学
呼吸系统医学呼吸系统医学
生物化学生物化学

背景情况:

过敏性喘包括2型炎症和eosinophilia.
酸耐酸酸酶5 (TRAP5),一种由巨细胞表达的酶,去酸化骨质 (OPN).
在喘中,OPN表达升高,这表明TRAP5在疾病中可能发挥作用.

研究的目的:

用小鼠模型研究TRAP5在过敏呼吸道炎症中的作用.
确定TRAP5对免疫细胞招募,细胞因子产生和喘炎症反应的影响.

主要方法:

卵胺 (OVA) 诱导的过敏呼吸道炎症模型在野生型 (WT) 和Trap5淘汰赛小鼠中.
介素-33 (IL-33) 诱导的2型炎症模型.
多重免疫试验用于细胞因子分析.
用于基因表达造型的定量PCR (qPCR).
流细胞计和免疫光检测用于细胞计数.
在体外乙酸酶化学毒性测试.

主要成果:

在WT和Trap5小鼠中,OVA诱导的炎症引起了病变和粘液的产生.
陷5小鼠的IL-5和IL-13水平较低,基因表达变化 (上调Il-17a,下调Il-33),以及支气管支气管洗液中乙素减少.
在体外,非酸化的OPN,但不是酸化的OPN,增强了埃索诺菲尔化学反应,这种作用被α4β1整合素抑制剂抑制.
IL-33模型在WT和Trap5小鼠中显示了类似的炎症反应.

结论:

TRAP5对于免疫细胞的招募至关重要,包括埃索诺菲尔细胞,并调节过敏性喘的炎症反应概况.
TRAP5通过影响细胞因子水平和基因表达,影响过敏呼吸道炎症.
TRAP5代表了对过敏性喘的潜在治疗标.

关键词:

喘喘是一种埃索诺菲尔细胞是什么意思这里有IL-33和IL-33.骨质疏松素是一种骨质疏松素.在TRAP5/ACP5中使用.

更多相关视频

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation

Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation

Published on: July 23, 2012

相关概念视频

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...